Header Image

NTC NEXT CONGRESS

March 4th
10:00 h.

OPENING

10:20 - 11:00 h.

HEALTH CLAIMS AND NOVEL FOODS: WHAT MAKES A NOVEL FOOD AND HOW TO ENSURE MESSAGING OPPORTUNITIES?

Prof. Andreu Palou. Prof. of Biochemistry and Molecular Biology of the University of Balearic Islands (UIB), Director of of Laboratory of Molecular Biology, Nutrition and Biotechnology of the UIB, Member of the Board of the CIBEROBN

11:00 – 11:40 h.

NANOTECHNOLOGY IN FOOD PACKAGING TECHNOLOGY.

Prof. Cristina Nerin. Professor of Analytical Chemistry, Director of Grupo GUIA-Instituto de Investigación en Ingeniería de Aragón (I3A) Ingeniería y Arquitectura (EINA)

11:40 – 12:00 h.

BREAK

12:00 – 12:40 h.

BOTANIC SUBSTANCES: FUNCTIONAL PROPERTIES.

Botanicals must be intended as “fiber, juice, oil, pulp, tissue, or other components derived from plants and used in cosmetics, food supplements, personal care products, or pharmaceutical”. In the last years, they have reached a large consideration as healthy component of food.
Botanical substances may exert functional activity in order to prevent health diseases. Due to their antioxidant and antimicrobial activities, they can be used as preservative agents in food and as source of functional food components, like as dietary fibers, terpenes, polyphenols, phytosterols and phytostanols, polyunsaturated fatty acid (Omega-3 fatty acid), organ Sulphur compounds.
The assessment of safety of botanicals and botanical substances is very important and comprehend also their use in food. This concept involves also the intended use and exposure, history of use, product comparison, toxicological information.
Last but not least, the legislation adopted in EU and particularly the claims substantiation must be examined.
All these arguments will be discussed in the presentation.

Prof. Mauro Serafini.Prof. of Biological Sciences, Pharmacognosis, Medicinal Plants of University of Roma ”La Sapienza”, Advisor of Research, Scientific Expert named by Italian Ministry of Health for the European BELFRIT Project, Scientific Researcher on Micotoxicology, Medicinal Plants and Nutrition

12:40 – 13:20 h.

FEEDING FOR FEEDING OLD PERSONS TODAY AND AT THE FUTURE.

Prof. Carmen Gómez-Candela. Prof. of Clinical Nutrition and Dietetic of University-Hospital La Paz(Madrid), Director of Research Group on Nutritional and Functional Health Research Institute, President of the Spanish Society od Applied Basic Nutrition(SENBA)

13:20 – 14:00 h.

INTRODUCTION TO THE EUROPEAN UNION & NUTRACEUTICALS: AN INSIDE-OUT APPROACH.

In a new European political context falling into place, the aim of this panel is to provide you with insights into the labyrinth that is the regulation-making process alongside the greener priorities of the new European Commission and European Parliament. This presentation will as such provide a broad understanding of the new dynamics and priorities as well as what implications could be expected for the nutraceuticals industry.

Eduardo Mulas (Partner) & Alex Bocquillion (Account Manger) EPPA
Partner and Account Manager

14:00 – 15:00 h.

BREAK

15:00 – 15:40 h.

HOW TO SUBSTANTIATE HEALTH CLAIMS ELICITED BY NUTRACEUTICALS. THE EFSA REGULATORY FRAMEWORK.

Dra. Ana Aldea. Clinical Research Coordinator Department of Hospital del Mar Medical Research Institute

15:40 – 16:20 h.

AFFRON®: CLINICAL EVIDENCE OF THE ANTIDEPRESSANT AND MOOD ENHANCER EFFECTS OF A SAFFRON EXTRACT.

Currently, more than 300 million people suffer from depression in the world and up to 20% of all humans will experience it at least once in their lifetime. It is the world’s biggest disabling cause among neurological and mental diseases. The talk will expose the evidence of efficacy obtained from clinical trials in humans with very low doses of affron®, a saffron extract, in people with depression after short periods of administration and without side effects. These facts allow affron® to be posed as a first-order natural therapeutic tool in the treatment of problems related to mood and depression.

Daniel González. PHARMACTIVE
R&D Researcher Pharmactive Biotech Products

16:20 – 17:00 h.

PROTECTING SUPPLEMENT BRANDS WITH THE HELP OF THIRD-PARTY CERTIFICATION – AN EXAMPLE FOR APPROACHING A GROWING PROBLEM

The global dietary supplements industry is growing at a rapid speed, with new brands emerging almost on a daily basis. As a manufacturer it is important to stay on top of these developments and differentiate your brand from the competition. Promoting public health and protecting the end consumer by ensuring that products are safe for human consumption is just one side of the equation. It is also important to protect your own brand and minimize risk. Our industry is measured against the “black sheep” who distribute products with wrong label information and potential contamination with harmful substances. Independent and accredited third-party certification that ensures regulatory compliance, truthful labelling and product safety contributes to overcome this issue and helps create public trust in a supplement brand. This presentation provides an overview of best practices for how to approach this problem.

David Trosin. NSF INTERNATIONAL
General Manager, NSF Dietary Supplements NSF International

March 5th
10:20 – 11:00 h.

ADAPTOGENIC AND NOOTROPIC  SUBSTANCES: INTENDED TO OPTIMIZE FUNCTIONAL FOODS 

Adaptogenic substances
They are a natural substances that according to Systemic Theory, basically plants and herbal, that provide special nutrients that help to human body to reach an optimum mental yielding and physical performance.
Is a pharmacological substance capable to produce in a human organism an upper resistant state of non specific resistance, that allows to prevent the stress symptoms in order to adapt to an exceptional effort.
An adaptogen will not cause secondary effects, shall have a modulator effect, do not have addiction causing and must transfer their propertis to whom consumes it. Simply speaking must gives negative entropy to consumer because it transfer survival to global system.
There are a very limited number of adaptogens, the main types are: Rhodiola rosae, Panax ginseng, Whitania sonifera, Ashwaghanda, Bacopa monnieri, Maitake, Schizandra y Chia (cereal) (because contains 11 saponin substances)
Nootropic substances
Nootropic substances, mainly are both natural and synthetic ingredients with very special molecular structure, that used at certain levels shows brain properties functioning of gnosis: mental processes related the memory, intelligence, attention management and creativity augmentation. Therefore they can become useful to improve the yielding and mental agility, that human needs to solve the main complex and difficult tasks, as well to cognitive prevention.
Some characteristic to be into account are the fact they don´t produce nor secondary adverse effects neither chemical dependency, this property is the most important difference related with stimulants like amphetamins.
Main known nootropic substances are the following: Acetyl-coline, Coline, Galantamine, Rosmarinus officinalis, Salvia officinalis, Gingko biloba, Theanine, Vincamine, Ubiquinone, Phisostigmine, Lycoris radiata, Vitamine B5, DMAE (Dimethylethanolamine), Selank.

Prof. Andrés Gavilán. President of AFCA (Spanish association for food additives and food supplements makers and traders), Prof. of National of Health School Carlos III on Upper Diploma in Food, Nutrition and Public Health, Dr. Chemical Sciences, President of Technical Sub-Committee (CTN34/SC4) on Food Analysis Horizontal Methods.

11:00 – 11:40 h.

COMPONENTS OF PHYTOCHEMICALS GUT MICROBIOTA MICROBIOTA INTERACTIONS: EFFECTS IN HUMAN  HEALTH.

Prof. Francisco A. Tomás Barberán. Prof. of Analytical Chemical at University of Murcia, Prof. Analytical Research of CEBAS(CSIC) and Number Member Murcia Region Sciencies Academy

11:40 – 12:00 h.

BREAK

12:00 – 12:40 h.

TOWARDS AN (UNAVOIDABLE?) EUROPEAN REGULATORY FRAMEWORK FOR NUTRACEUTICALS: HINDERING OR STIMULATING INNOVATION?  

Currently, nutraceuticals represent an emerging area with booming growth, although not yet benefitting from a specific definition at EU level distinct from other food-derived categories. In this context, the potential development of a well-drafted regulatory framework at EU level could further stimulate competitiveness, innovation and investment in the sector. However, risks could also emerge from an ill-drafted regulation. This panel will address possible scenarios of a potential future legislation at EU level addressing nutraceuticals, including specific cases of similar precedents under other regulatory frameworks (Novel Food Regulation, Biostimulants …).

Eduardo Mulas (Partner) & Alex Bocquillion (Account Manger) EPPA
Partner and Account Manager

12:40 – 13:20 h.

ACCELERATION AND IMPROVEMENT OF THE INNOVATION PROCESSES EFFICIENCY IN THE DIGITAL ERA THROUGH BUSINESS INTELLIGENCE.

Innovation processes are getting shorter, and in addition to this, there are an increasement of innovative product launch into the market and hyper-informed consumers that are concerned about its health. The huge amount of information and data related to new substances or active principles for nutraceuticals formulation, requires a high analysis time that, in many cases, represents an opportunity cost for companies.

The digitalization of those processes used to watch the competitive landscape and to massively process data, reduces analysis times and supports business opportunities´ identification considering many variables

David Martínez. AINIA
Manager of Digital Information and Communication Technologies Department

13:20 – 14:00 h.

NUTRACEUTICALS FOR THE IMPROVEMENT OF COGNITIVE FUNCTIONING. PRACTICAL ASPECTS IN THE CLINICAL DEVELOPMENT

Rafael de la Torre. IMIM
Director of the Neurosciences Research Program of the Hospital del Mar Medical Research Institute

14:00 – 15:00 h.

BREAK

15:00 – 15:40 h.

MICROBIOTA MODULATION: A NEW STRATEGY TO IMPROVE IRRITABLE BOWEL SYNDROME SYMPTOMS.

Essential oils have well-known anti-inflammatory and antimicrobial properties. They are rapidly assimilated in the small intestine and, once in circulation, are rapidly eliminated by the liver and kidneys. BIOintestil® is a patented blend of Cymbopogon martinii (Roxb.) essential oil with a delayed release capable to reach the colon. Into the colon, BIOintestil® exerts its marked anti-inflammatory action directed against inflammatory mediators deriving from the Cyclooxygenase 2 pathway and modulates the intestinal microbiota causing an increase in microbial diversity associated with a strong and significant increase in single microbial species, such as Faecalibacterium, Blautia, and Prevotella, whose decrease is part of the IBS-associated dysbiosis. BIOintestil® was studied in vitro, in preclinical study and in a pilot open label trial that involved 19 IBS patients. A randomized double-blind placebo-controlled clinical trial is ongoing, with excellent interim results. Orally administered BIOintestil®, in the double blind controlled clinical trial, strongly improved the clinical symptoms of colitis in IBS patients by significantly reducing the score recorded by the VAS-IBS questionnaire. Clinical improvement was associated with a significant reduction of bloating, intestinal pain and regularization of bowel habit, especially in IBS patients with the diarrheal subtype. In conclusion BIOintestil® is a powerful component for food supplement targeted to the treatment of IBS patients.

Enzo Spini. FAGRÓN IBERIA. CEO Targeting Gut Disease

15:40 – 16:20 h.

FROM GENETIC PROGRAMMING TO UNEXPECTED EPIGENETIC. NUTRIENTS, NON NUTRIENTS AND INTESTINAL MICROBIOTA CONTRIBUTION.

It has been generally accepted that the inheritance corresponded to the DNA located on the nucleus, and that depending on the nucleotide sequence, the proteins synthesis was specifically programmed on each individual. It was added to this knowledge the presence of another mitochondrial, transmitted by maternal line. Afterwards, at the turn of the 21st century it was discovered that, sometimes, a genotype expression is also modified by some other factors like different types of radiations, presence of chemical substances like organic solvents and diet above all.
Within the diet, there are included some of the natural food components as toxins, antinutrients, bioactive ingredients or added through food techniques or agrifood techniques as Xenobiotics or neoformed components.
If in addition to all this, we add the food interactions with the food environment; coffee, tobacco, alcohol and medicinal herbs, we could assure that it means far less what we eat than how we treat what we eat. The steps taken are, in most of the cases, the reason of the epigenetic changes that do not modify the genotype but together with the endocrine disrupters are the cause to avoid expressing some genotype characteristics or the expression something unexpected.
Finally, If we make a reflexion on the influence that those processes have got on the microbiota, specially on the intestines and the effect of those modifications on the human health, it could be convenient to revise the described process to reduce the impact on the public health as much as possible.

Dra. Maite García Jiménez. Pharmacist, Biologist and Public Nutricionist, Director of Uppers Diplomas of Food, Nutrition and Public Health at National School (Health Institute Carlos III (1992-2016)

16:20 – 17:00 h.

NEW CONCEPT FOR BEAUTY AND SKIN HEALTH.

The beauty from within market has just started and will continue to grow. Beauty products from around the world show a positive growth according to Innova Market Insights. Next to topical creams, nutritional supplements are growing. During this conference we will show a new concept based on a natural collogen booster, combined with a mineral that has the most natural absorption and superior bioavailality. A ready to go new concept for the beauty from within market that will help you to differentiate in the market.

Nelson Talavera Ruiz. VANEEGHEIN. Technical Manager

Top